We are live on
!
Find out more
PCA
Pallas Capital Advisors Portfolio holdings
AUM
$3.25B
1-Year Est. Return
40.07%
This Fund
S&P 500
This Quarter
Est. Return
+24.84%
1 Year Est. Return
+40.07%
3 Year Est. Return
+71.82%
5 Year Est. Return
+73.39%
10 Year Est. Return
–
AUM
$3.25B
AUM Growth
+$591M
(+22%)
Cap. Flow
+$106M
Cap. Flow
% of AUM
3.25%
Top 10 Holdings %
Top 10 Hldgs %
33.93%
Holding
1,102
New
240
Increased
395
Reduced
355
Closed
68
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs ActiveBeta International Equity ETF
GSIE
|
+$15.5M |
| 2 |
NVIDIA
NVDA
|
+$9.58M |
| 3 |
Apple
AAPL
|
+$5.09M |
| 4 |
Janus Henderson Mortgage-Backed Securities ETF
JMBS
|
+$4.72M |
| 5 |
OGC
OceanaGold Corp
OGC
|
+$4.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$13.4M |
| 2 |
WisdomTree Floating Rate Treasury Fund
USFR
|
+$6.39M |
| 3 |
Marvell Technology
MRVL
|
+$6.11M |
| 4 |
Danaher
DHR
|
+$5.73M |
| 5 |
Western Digital
WDC
|
+$5.09M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 32.97% |
| 2 | Healthcare | 22.42% |
| 3 | Technology | 13.1% |
| 4 | Industrials | 6.42% |
| 5 | Financials | 6.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LPRO
1001
DELISTED
Open Lending Corp
LPRO
| $34.8K | ﹤0.01% |
11,175
-2,426
| -18% | -$4.96K |
|
1002
Larimar Therapeutics
LRMR
$395M
| $30.8K | ﹤0.01% |
10,085
-1,077
| -10% | -$4.28K |
|
1003
Nkarta
NKTX
$201M
| $30.7K | ﹤0.01% |
+10,851
| New | +$30.6K |
|
1004
JELD-WEN Holding
JELD
$164M
| $30.2K | ﹤0.01% |
+20,166
| New | +$31.1K |
|
1005
Conduent
CNDT
$264M
| $30.2K | ﹤0.01% |
+20,681
| New | +$32.1K |
|
1006
Eve Holding
EVEX
$718M
| $30.2K | ﹤0.01% |
+12,029
| New | +$34.7K |
|
1007
Kosmos Energy
KOS
$1.69B
| $25.3K | ﹤0.01% |
+12,007
| New | +$33.4K |
|
1008
Allogene Therapeutics
ALLO
$598M
| $24.6K | ﹤0.01% |
11,844
-14,394
| -55% | -$31.6K |
|
1009
AMC Entertainment Holdings
AMC
$2.42B
| $24.2K | ﹤0.01% |
+12,731
| New | +$21.9K |
|
1010
Zevia
ZVIA
$100M
| $22.8K | ﹤0.01% |
+13,970
| New | +$19K |
|
1011
8x8 Inc
EGHT
$261M
| $20.9K | ﹤0.01% |
12,221
-9,051
| -43% | -$18.2K |
|
1012
Quantum-Si Incorporated
QSI
$169M
| $20.6K | ﹤0.01% |
23,320
-2,437
| -9% | -$2.32K |
|
|
BZAI
1013
Blaize Holdings
BZAI
$89.1M
| $19.6K | ﹤0.01% |
14,206
+1,503
| +12% | +$2.64K |
|
1014
MaxCyte
MXCT
$124M
| $19.2K | ﹤0.01% |
+15,629
| New | +$15.6K |
|
1015
Blend Labs
BLND
$307M
| $18.8K | ﹤0.01% |
10,969
-3,402
| -24% | -$5.43K |
|
1016
Hain Celestial
HAIN
$52.1M
| $18.6K | ﹤0.01% |
33,213
+11,656
| +54% | +$8.65K |
|
1017
Getty Images
GETY
$96.6M
| $16.8K | ﹤0.01% |
+19,515
| New | +$16.9K |
|
1018
Prairie Operating Co
PROP
$45.3M
| $15.7K | ﹤0.01% |
+21,801
| New | +$23.5K |
|
1019
Coherus Oncology
CHRS
$190M
| $15.4K | ﹤0.01% |
11,014
-531
| -5% | -$867 |
|
1020
Akebia Therapeutics
AKBA
$248M
| $14.2K | ﹤0.01% |
+12,474
| New | +$14.8K |
|
1021
ADC Therapeutics
ADCT
$135M
| $13.5K | ﹤0.01% |
+12,601
| New | +$36.8K |
|
1022
Myomo
MYO
$52.7M
| $12.8K | ﹤0.01% |
+12,308
| New | +$12K |
|
1023
Lucid Diagnostics
LUCD
$149M
| $12.7K | ﹤0.01% |
+11,874
| New | +$12.8K |
|
1024
Heron Therapeutics
HRTX
$59.9M
| $11K | ﹤0.01% |
+25,699
| New | +$20.6K |
|
1025
Nerdy
NRDY
$74M
| $9.24K | ﹤0.01% |
+672
| New | +$8.78K |
|
Similar funds
TAM
SSM
MWM
NCL
SCM
FFN
TMAM
MTIM
Pallas Capital Advisors's Q2 2026 Portfolio in Review
As of Q2 2026, Pallas Capital Advisors held 1,102 positions worth $3.25B, up 22% from $2.66B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Pallas Capital Advisors deployed $106M of net new capital in Q2 2026, opening 240 new positions and adding to 395 existing holdings. Its largest new stake was OceanaGold Corp: 150,575 shares worth $3.78M.
By sector, the portfolio is most concentrated in Miscellaneous at 33% of assets, down from 35% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was iShares 1-3 Year Treasury Bond ETF, an estimated $13.4M trimmed.
- Pallas Capital Advisors's largest Q2 2026 buy was OceanaGold Corp: 150,575 shares worth $3.78M.
- Pallas Capital Advisors added most to Goldman Sachs ActiveBeta International Equity ETF in Q2 2026, an estimated $15.5M increase.
- Pallas Capital Advisors's biggest Q2 2026 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $13.4M.
- Pallas Capital Advisors fully exited MarketAxess Holdings in Q2 2026, selling an estimated $1.84M.
- Pallas Capital Advisors's ten largest holdings make up 34% of its $3.25B portfolio in Q2 2026.
- Pallas Capital Advisors opened 240 new positions and closed 68 in Q2 2026.
- Pallas Capital Advisors's portfolio value rose 22% quarter-over-quarter to $3.25B.
Based on Pallas Capital Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.